Members |
targetComponentId |
Metastatic lobular carcinoma to left female breast |
Metastatic lobular carcinoma (disorder) |
Metastatic lobular carcinoma to right female breast |
Metastatic lobular carcinoma (disorder) |
sekundært malignt neoplasme i areola mamma hos kvinde |
Metastatic malignant neoplasm to areola (disorder) |
sekundært malignt neoplasme i areola mammae hos mand |
Metastatic malignant neoplasm to areola (disorder) |
sekundært malignt neoplasme i processus axillaris i mamma hos kvinde |
Metastatic malignant neoplasm to axillary tail of breast (disorder) |
sekundært malignt neoplasme i centrale del af mamma hos kvinde |
Metastatic malignant neoplasm to central portion of breast (disorder) |
Metastatic malignant neoplasm to colon and/or rectum |
Metastatic malignant neoplasm to cecum and/or colon and/or rectum (disorder) |
sekundært malignt neoplasme i ektopisk mammavæv hos kvinde |
Metastatic malignant neoplasm to ectopic site of breast (disorder) |
sekundært malignt neoplasme i ektopisk brystvæv hos mand |
Metastatic malignant neoplasm to ectopic site of breast (disorder) |
sekundært malignt neoplasme i mamma hos kvinde |
Metastatic malignant neoplasm to breast (disorder) |
sekundært malignt neoplasme i nedre mediale kvadrant af mamma hos kvinde |
Metastatic malignant neoplasm to lower inner quadrant of breast (disorder) |
sekundært malignt neoplasme i nedre laterale kvadrant af mamma hos kvinde |
Metastatic malignant neoplasm to lower outer quadrant of breast |
Metastatic malignant neoplasm to lymph node from primary malignant neoplasm of female breast |
Metastatic malignant neoplasm to lymph node |
sekundært malignt neoplasme i mamma hos mand |
Metastatic malignant neoplasm to breast (disorder) |
sekundært malignt neoplasme i brystvorte hos kvinde |
Metastatic malignant neoplasm to nipple (disorder) |
sekundært malignt neoplasme i brystvorte hos mand |
Metastatic malignant neoplasm to nipple (disorder) |
sekundært malignt neoplasme i øvre mediale kvadrant af mamma hos kvinde |
Metastatic malignant neoplasm to upper inner quadrant of breast |
sekundært malignt neoplasme i øvre laterale kvadrant af mamma hos kvinde |
Metastatic malignant neoplasm to upper outer quadrant of breast (disorder) |
Metastatic pilomatrix carcinoma to skin |
Metastatic pilomatrix carcinoma (disorder) |
Metastatic renal cell carcinoma to kidney |
Metastatic renal cell carcinoma |
Metastatic renal cell carcinoma to kidney except renal pelvis |
Metastatic renal cell carcinoma |
Metatarsal phalangeal joint flap |
Flap (substance) |
Methacholine 2.5% eye drops |
Product containing precisely methacholine 25 milligram/1 milliliter conventional release eye solution (clinical drug) |
methacholinchlorid 100 mg pulver |
Product containing only methacholine (medicinal product) |
methadon 10 mg/5 ml mikstur |
Product containing precisely methadone hydrochloride 2 milligram/1 milliliter conventional release oral solution (clinical drug) |
methadonhydrochlorid 40 mg dispergibel tablet |
Product containing precisely methadone hydrochloride 40 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
methamphetaminhydrochlorid 10 mg tablet med modificeret udløsning |
Metamfetamine only product in oral dose form |
Methamphetamine hydrochloride 10mg prolonged-release oral tablet |
Metamfetamine only product in oral dose form |
methamphetaminhydrochlorid 15 mg tablet med modificeret udløsning |
Metamfetamine only product in oral dose form |
Methamphetamine hydrochloride 15mg prolonged-release oral tablet |
Metamfetamine only product in oral dose form |
methamphetaminhydrochlorid 5 mg tablet med modificeret udløsning |
Metamfetamine only product in oral dose form |
Methamphetamine hydrochloride 5mg prolonged-release oral tablet |
Metamfetamine only product in oral dose form |
methicillinresistent Staphylococcus aureus-infektion, der komplicerer graviditet, fødsel eller barselsperiode |
Methicillin resistant Staphylococcus aureus detected (finding) |
Methicillin resistant staphylococcus aureus as the cause of diseases classified to other chapters |
Methicillin resistant Staphylococcus aureus infection (disorder) |
Methicillin resistant staphylococcus aureus as the cause of diseases classified to other chapters |
Methicillin resistant Staphylococcus aureus infection (disorder) |
Method appointment made NOS |
Method appointment made |
Method appointment made NOS |
Method appointment made |
Method of administration for tube feeding of patient |
The delivery technique for infusion of enteral nutrition formula distal to the oral cavity via a tube inserted into the gastrointestinal tract. |
Method of delivery NOS |
Delivery procedure |
Method of delivery NOS |
Delivery procedure |
Methods of operation NOC |
Intentional, structural alteration of the human body by mechanical, thermal, light-based, electromagnetic, or chemical means, and/or by the incision or destruction of tissues using instruments to cut, burn, vaporize, freeze, suture, probe, or manipulate by closed reductions. |
Methods of operation NOC NOS |
Intentional, structural alteration of the human body by mechanical, thermal, light-based, electromagnetic, or chemical means, and/or by the incision or destruction of tissues using instruments to cut, burn, vaporize, freeze, suture, probe, or manipulate by closed reductions. |
methohexitalnatrium 5 g, pulver til injektionsvæske, opløsning, hætteglas |
Product containing only methohexital (medicinal product) |
methoxsalen 20 µg/ml injektionsvæske, opløsning |
Methoxsalen 20 microgram/mL solution for injection |
methylaminolevulinat 168 mg/g creme til topikal anvendelse |
Methyl aminolevulinate (as methyl aminolevulinate hydrochloride) 168 mg/g cutaneous cream |
Methyl methacrylate embolism |
Foreign body embolus |
Methyl parathion |
Hexaethyl tetraphosphate |
methylcellulose 1 % øjendråber |
Methylcellulose 10 mg/mL eye solution |
Methylcitrat |
2-methylcitrate (substance) |
måling af methylcitrat |
2-methylcitrate measurement (procedure) |
metylenblåt 1 % injektionsvæske, opløsning, hætteglas |
Methylthioninium chloride only product in parenteral dose form |
Methylene blue 65mg tablet |
Methylthioninium chloride 65 mg oral tablet |
Methylenedioxymethamphetamine dependence with current use |
Methylenedioxymethamphetamine dependence |
Methylobacterium animovorans |
Methylorubrum aminovorans |
Methylobacterium lusitanum |
Methylorubrum rhodesianum |
methylphenidat 10 mg tyggetablet |
Methylphenidate hydrochloride 10 mg chewable tablet |
methylphenidat 2,5 mg tyggetablet |
Product containing precisely methylphenidate hydrochloride 2.5 milligram/1 each conventional release chewable tablet (clinical drug) |
methylphenidat 5 mg tyggetablet |
Methylphenidate hydrochloride 5 mg chewable tablet |
methylphenidathydrochlorid 10 mg tablet med modificeret udløsning |
Product containing only methylphenidate in oral dose form (medicinal product form) |
Methylphenidate hydrochloride 10mg prolonged-release oral tablet |
Product containing only methylphenidate in oral dose form (medicinal product form) |
methylphenidathydrochlorid 72 mg tablet med modificeret udløsning |
Product containing only methylphenidate in oral dose form (medicinal product form) |
Methylphenidate hydrochloride 72mg prolonged-release oral tablet |
Product containing only methylphenidate in oral dose form (medicinal product form) |
methylprednisolon 125 mg pulver og solvens til injektionsvæske, opløsning, hætteglas |
Methylprednisolone (as methylprednisolone sodium succinate) 125 mg powder for solution for injection vial |
methylprednisolon 1 g pulver og solvens til injektionsvæske, opløsning, hætteglas |
Product containing precisely methylprednisolone (as methylprednisolone sodium succinate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
methylprednisolon 2 g pulver og solvens til injektionsvæske, opløsning, hætteglas |
Product containing precisely methylprednisolone (as methylprednisolone sodium succinate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
methylprednisolon 40 mg pulver og solvens til injektionsvæske, opløsning, hætteglas |
Methylprednisolone (as methylprednisolone sodium succinate) 40 mg powder for solution for injection vial |
methylprednisolon 500 mg pulver og solvens til injektionsvæske, opløsning, hætteglas |
Methylprednisolone (as methylprednisolone sodium succinate) 500 mg powder for solution for injection vial |
Methylprednisolone sodium su 1000mg/8mL injection |
Product containing precisely methylprednisolone (as methylprednisolone sodium succinate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
methylprednisolonnatriumsuccinat 125 mg injektionsvæske |
Methylprednisolone (as methylprednisolone sodium succinate) 125 mg powder for solution for injection vial |
methylprednisolonnatriumsuccinat 125 mg/2 ml pulver |
Methylprednisolone (as methylprednisolone sodium succinate) 125 mg powder for solution for injection vial |
Methylprednisolone sodium su 125mg/vial powder for injection |
Methylprednisolone (as methylprednisolone sodium succinate) 125 mg powder for solution for injection vial |
Methylprednisolone sodium su 1g/vial injection |
Product containing precisely methylprednisolone (as methylprednisolone sodium succinate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Methylprednisolone sodium su 40mg powder |
Methylprednisolone (as methylprednisolone sodium succinate) 40 mg powder for solution for injection vial |
methylprednisolonnatriumsuccinat 40 mg/ml pulver |
Methylprednisolone (as methylprednisolone sodium succinate) 40 mg powder for solution for injection vial |
Methylprednisolone sodium su 500mg/4mL injection |
Methylprednisolone (as methylprednisolone sodium succinate) 500 mg powder for solution for injection vial |
methylprednisolonnatriumsuccinat 125 mg pulver til injektionsvæske, opløsning, hætteglas |
Methylprednisolone (as methylprednisolone sodium succinate) 125 mg powder for solution for injection vial |
methylprednisolonnatriumsuccinat 1 g pulver til injektionsvæske, opløsning, hætteglas |
Product containing precisely methylprednisolone (as methylprednisolone sodium succinate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
methylprednisolonnatriumsuccinat 2 g pulver til injektionsvæske, opløsning, hætteglas |
Product containing precisely methylprednisolone (as methylprednisolone sodium succinate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
methylprednisolonnatriumsuccinat 40 mg pulver til injektionsvæske, opløsning, hætteglas |
Methylprednisolone (as methylprednisolone sodium succinate) 40 mg powder for solution for injection vial |
Methylprednisolone sodium succinate 500g powder for injection solution vial |
Methylprednisolone (as methylprednisolone sodium succinate) 500 mg powder for solution for injection vial |
methylprednisolonnatriumsuccinat 500 mg pulver til injektionsvæske, opløsning, hætteglas |
Methylprednisolone (as methylprednisolone sodium succinate) 500 mg powder for solution for injection vial |
methyltetrahydrophtalisk anhydrid-specifikt ekstrakt |
Methyltetrahydrophtalic anhydride |
Methyltransferase |
Methyltransferase |
metipranolol 0,1% øjendråber |
Metipranolol 1 mg/mL eye solution |
Metipranolol 0.3% |
Metipranolol 3 mg/mL eye solution |
Metipranolol 0.3% conventional release eye drops |
Metipranolol 3 mg/mL eye solution |
metipranolol 0,3% øjendråber |
Metipranolol 3 mg/mL eye solution |
Metipranolol 0.3% ophthalmic solution |
Metipranolol 3 mg/mL eye solution |
metipranolol 0,3% øjendråber til engangsbrug |
Metipranolol 3 mg/mL eye solution |
Metipranolol 0.3%wv solution |
Metipranolol 3 mg/mL eye solution |
Metoclopramide |
Product containing metoclopramide (medicinal product) |
Metoclopramide hydrochloride |
Metoclopramide hydrochloride |
Metoclopramide hydrochloride 5mg/mL |
Metoclopramide (as metoclopramide hydrochloride) 5 mg/mL solution for injection |
metoclopramidhydrochlorid 5 mg/ml infusionsvæske, opløsning, ampul |
Metoclopramide (as metoclopramide hydrochloride) 5 mg/mL solution for injection |
metoclopramidhydrochlorid 5 mg/ml injektionsvæske, opløsning, ampul a 2 ml |
Metoclopramide (as metoclopramide hydrochloride) 5 mg/mL solution for injection |
Metoclopramide hydrochloride 5mg/mL solution |
Metoclopramide (as metoclopramide hydrochloride) 5 mg/mL solution for injection |
metoprololsuccinat 100 mg tablet med modificeret udløsning |
Product containing only metoprolol in oral dose form (medicinal product form) |
Metoprolol succinate 100mg prolonged-release oral tablet |
Product containing only metoprolol in oral dose form (medicinal product form) |
metoprololsuccinat 200 mg tablet med modificeret udløsning |
Product containing only metoprolol in oral dose form (medicinal product form) |
Metoprolol succinate 200mg prolonged-release oral tablet |
Product containing only metoprolol in oral dose form (medicinal product form) |
metoprololsuccinat 25 mg tablet med modificeret udløsning |
Product containing only metoprolol in oral dose form (medicinal product form) |